MediFind
Condition

Familial Ventricular Tachycardia

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: COVID-19
  • Journal: Journal of clinical medicine
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 10668655
  • Published —
The study researched the safety of Hydroxychloroquine in patients with COVID-19.
Latest Advance
Study
  • Condition: Inherited Cardiac Arrhythmia Syndrome in Children
  • Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
  • Treatment Used: Implantable Cardioverter Defibrillator (ICD) Implantation
  • Number of Patients: 30
  • Published —
This study analyzed and summarized the diagnosis and treatment experience of common inherited cardiac arrhythmia (heart quivering) syndrome in pediatric patients, and explored the most appropriate therapy.
Latest Advance
Study
  • Condition: Catecholaminergic Polymorphic Ventricular Tachycardia (CVPT)
  • Journal: Medicine
  • Treatment Used: Flecainide
  • Number of Patients: 485
  • Published —
This review of the literature investigated the effectiveness and tolerability of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia (rapid heart beat; CPVT).
Latest Advance
Study
  • Condition: Patients with Implantable Cardioverter Defibrillators (ICDs)
  • Journal: Journal of electrocardiology
  • Treatment Used: Amiodarone
  • Number of Patients: 612
  • Published —
This study clarified the association between atrial fibrillation (heart quivering; AF) and ventricular arrhythmias (heart abnormal rhythms;VAs) and investigated the effect of amiodarone on the incidence of ventricular arrhythmias in patients with implantable cardioverter defibrillators (ICDs).
Latest Advance
Study
  • Condition: Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
  • Journal: Heart rhythm
  • Treatment Used: Implantable Cardioverter-Defibrillator (ICD)
  • Number of Patients: 1429
  • Published —
This study characterized the use and outcomes of implantable cardioverter-defibrillators (ICDs) in patients with catecholaminergic polymorphic ventricular tachycardia (increased heart rhythm; CPVT).
Latest Advance
Study
  • Condition: Atrial fibrillation/Cardiac resynchronization therapy implantable cardioverter-defibrillator
  • Journal: European journal of heart failure
  • Treatment Used: Atrioventricular junction ablation versus rate-slowing drugs.
  • Number of Patients: 3358
  • Published —
This study evaluated whether atrioventricular junction ablation in patients with cardiac resynchronization therapy implantable cardioverter-defibrillator (ICD) and with permanent atrial fibrillation has a positive impact on ICD shocks and hospitalizations compared with rate-slowing drugs.